Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2012; 18(9): 944-951
Published online Mar 7, 2012. doi: 10.3748/wjg.v18.i9.944
Published online Mar 7, 2012. doi: 10.3748/wjg.v18.i9.944
Table 1 Tokyo guideline diagnostic criteria and severity assessment of acute cholecystitis
Diagnosis criteria |
A: Local signs of inflammation |
Murphy’s sign |
Rright upper quadrant mass/pain/tenderness |
B: Systemic signs of inflammation |
Fever |
Elevated C-reactive protein |
Elevated white blood cell count |
C: Imaging findings |
Sonographic Murphy sign |
Thickened gallbladder wall |
Enlarged gallbladder |
Pericholecystic fluid collection |
Sonolucent layer in the gallbladder wall |
Definite diagnosis |
One item in A and one in B are positive |
C confirms the diagnosis when acute cholecystitis is suspected clinically1 |
Severity assessment |
Mild (grade I) |
Acute cholecystitis does not meet the criteria of severe (grade III) or moderate (grade II) acute cholecystitis or acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low risk operative procedure |
Moderate (grade II) |
Elevated WBC count (> 18 000/mm3) |
Palpable tender mass in the right upper quadrant |
Duration of complains > 72 h2 |
Marked local inflammation (biliary peritonitis, pericholecystic abscess, hepatic abscess, gangrenous cholecystitis, emphysematous cholecystitis) |
Severe (grade III) |
Acute cholecystitis associated with dysfunction of any one of the following organs/systems |
Cardiovascular dysfunction (hypotension requiring treatment with dopamine ≥ 5 μg/kg per minute, or any dose of dobutamine) |
Neurological dysfunction (decreased level of consciousness) |
Respiratory dysfunction (PaO2/FiO2 ratio < 300) |
Renal dysfunction (oliguria, creatinine > 2.0 mg/dL) |
Hepatic dysfunction (PT-INR > 1.5) |
Table 2 Tokyo guideline diagnosis criteria and severity assessment of acute cholangitis
Diagnosis criteria (suspected diagnosis and definite diagnosis) |
Severity assessment |
A: Clinical context and clinical manifestations |
History of biliary disease |
Fever and/or chills |
Jaundice |
Abdominal pain (right upper quadrant or upper abdominal) |
B: Laboratory data |
Evidence of inflammatory response1 |
Abnormal liver function tests2 |
C: Imaging findings |
Biliary dilation, or evidence of etiology (stricture, stone, stent, etc.) |
Two or more items in A |
Charcot’s triad (2 + 3 + 4) |
Two or more items in A + both items in B + C |
Severity assessment |
Mild (grade I) |
Acute cholangitis that responds to initial medical treatment3 |
Moderate (grade II) |
Acute cholangitis that does not respond to initial medical treatmentc and is not accompanied by organ dysfunction |
Severe (grade III) |
Acute cholangitis that is associated with the onset of dysfunction at least in any one of the following organs/systems |
Cardiovascular system; hypotension requiring dopamine ≥ 5 μg/kg per minute, or any dose of dobutamine |
Nervous system: disturbance of consciousness |
Respiratory system: PaO2/FiO2 ratio < 300 |
Kidney: serum creatinine > 2.0 mg/dL |
Liver: PT-INR > 1.5 |
Hematological system: platelet count < 100 000/μL |
Table 3 Comparison of patients’ demographics and operative outcome between dingle-incision laparoscopic cholecystectomy for acute inflamed gallbladder and single-incision laparoscopic cholecystectomy for non-acute inflamed gallbladder
Patient demographics | SILC for AIG | SILC for non-AIG | P value |
n | 26 | 84 | |
Age (yr) median (range) | 61.5 (22-81) | 56.5 (31-81) | 0.06 |
Sex (male/female) | 12/14 | 42/42 | 0.82 |
BMI median (range) | 22.0 (18.4-29.4) | 22.2 (16.0-30.0) | 0.85 |
ASA score I/II/III | 14/11/1 | 65/19/0 | 0.02 |
Previous upper abdominal surgery (yes/no) | 2/24 | 4/80 | 0.63 |
Indication for operation | Acute cholecystitis 15 | Symptomatic gallstone 65 | |
Acute gallstone cholangitis 11 | Choledochlithiasis 2 | ||
No inflammation 17 | |||
Operative outcome | |||
Operative time (min) | 0.03 | ||
Median (range) | 97.5 (60-163) | 85 (45-195) | |
mean (SD) | 105.7 (31.9) | 91.0 (29.3) | |
Intra-abdominal adhesion none to mild/moderate/severe | 8/15/3 | 52/27/15 | 0.02 |
Gallbladder wall thickening | 16/2/8 | 66/14/4 | < 0.01 |
none to mild/moderate/severe | |||
IOC completion1 | 23/24 | 81/82 | 0.4 |
Conversion to open cholecystectomy | 2 | 2 | 0.24 |
Bile spillage | 9 | 15 | 0.1 |
Use of additional port site | 5 | 3 | 0.01 |
Complication (total) | 1 | 3 | 1.00 |
Wound infection | 1 | 2 | |
Bile duct injury | 0 | 1 |
Table 4 Comparison of patient demographics and operative outcome between single-incision laparoscopic cholecystectomy for acute inflamed gallbladder and traditional laparoscopic cholecystectomy for acute inflamed gallbladder
SILC for AIG | TLC for AIG | P value | |
Patient demographics | |||
n | 26 | 54 | |
Age (yr) median (range) | 61.5 (22-81) | 61 (25-89) | 0.94 |
Sex (male/female) | 14/12 | 34/20 | 0.47 |
BMI median (range) | 22.0 (18.4-29.4) | 22.8 (15.4-32.0) | 0.53 |
ASA score I/II/III | 14/11/1 | 25/25/4 | 0.73 |
Previous upper abdominal surgery (yes/no) | 2/24 | 5/49 | 0.59 |
Indication for operation | Acute cholecystitis 14 | Acute cholecystitis 29 | 0.81 |
Acute gallstone cholangitis 11 | Acute gallstone cholangitis 25 | ||
Max WBC count in acute phase | 0.78 | ||
WBC > 14 000 | 5 | 13 | |
WBC < 14 000 | 21 | 41 | |
Max CRP in acute phase | 0.44 | ||
CRP > 10 | 6 | 18 | |
CRP < 10 | 20 | 36 | |
Severity assessment by Tokyo Guidelines Grade I/II/III | 19/5/2 | 38/13/3 | 0.85 |
Day from onset to operation | 19 (6-111) | 20 (8-104) | 0.82 |
Clinical result | |||
Operative time (min) | 0.12 | ||
Median (range) | 97.5 (60-163) | 87.5 (35-245) | |
mean (SD) | 105.7 (31.9) | 94.7 (34.4) | |
Surgeon | 26/0 | 16/39 | |
Staff surgeon/surgical resident | |||
IOC completion1 | 23/24 | 42/49 | 0.26 |
Conversion to open cholecystectomy | 2 | 5 | 1 |
Bile spillage | 9 | 14 | 0.44 |
Complication | 1 | 7 | 0.26 |
- Citation: Sasaki K, Watanabe G, Matsuda M, Hashimoto M. Original single-incision laparoscopic cholecystectomy for acute inflammation of the gallbladder. World J Gastroenterol 2012; 18(9): 944-951
- URL: https://www.wjgnet.com/1007-9327/full/v18/i9/944.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i9.944